All lobbying filings

AVENUE SOLUTIONS

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 2

HR 1227
Alternatives to PAIN Act
S 475
Alternatives to PAIN Act

Lobbying activity 2

Health Issues

Monitor issues related to 340b; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)

Medicare/Medicaid

H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.